Differences in hospital-associated multidrug-resistant organisms and Clostridium difficile rates using 2-day versus 3-day definitions

Infect Control Hosp Epidemiol. 2014 Nov;35(11):1417-20. doi: 10.1086/678423. Epub 2014 Oct 8.

Abstract

We surveyed infection prevention programs in 16 hospitals for hospital-associated methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci, extended-spectrum β-lactamase, and multidrug-resistant Acinetobacter acquisition, as well as hospital-associated MRSA bacteremia and Clostridium difficile infection based on defining events as occurring >2 days versus >3 days after admission. The former resulted in significantly higher median rates, ranging from 6.76% to 45.07% higher.

Publication types

  • Comparative Study
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acinetobacter
  • Acinetobacter Infections / diagnosis*
  • Acinetobacter Infections / epidemiology
  • Bacteremia / diagnosis*
  • Bacteremia / epidemiology
  • Bacteremia / microbiology
  • California
  • Carrier State / diagnosis*
  • Carrier State / epidemiology
  • Carrier State / microbiology
  • Clostridioides difficile*
  • Cross Infection / diagnosis*
  • Cross Infection / epidemiology
  • Cross Infection / microbiology
  • Drug Resistance, Multiple, Bacterial
  • Enterocolitis, Pseudomembranous / diagnosis*
  • Enterocolitis, Pseudomembranous / epidemiology
  • Enterocolitis, Pseudomembranous / microbiology
  • Humans
  • Methicillin-Resistant Staphylococcus aureus
  • Practice Guidelines as Topic*
  • Prospective Studies
  • Staphylococcal Infections / diagnosis*
  • Staphylococcal Infections / epidemiology
  • Staphylococcal Infections / microbiology
  • Time Factors
  • Vancomycin-Resistant Enterococci
  • beta-Lactam Resistance